Proteomics Research - All You Need to Know About Emerging Innovations

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Following are the Major Objectives of this Study:

# To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

Recent Developments:

# In 2018, Thermo Fisher Scientific, Inc. and Symphogen formed a collaboration under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap LC/MS/MS system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In 2018, Thermo Fisher Scientific, Inc. launched TSQ Fortis Triple Quadrupole Mass Spectrometer and UHPLC-MS Ultrapure Solvents.

# In 2018, Agilent Technologies acquired Advanced Analytical Technologies, Inc. to enhance its technology base and provide a comprehensive set of solutions for NGS workflows.

# In 2017, Merck KGaA signed an MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development. Under the agreement, Merck would supply Mobius single-use systems, cell line, cell culture media, and chromatography to accelerate the development of biologic drugs.

Critical questions answered in the report:

# How will the current technological trends affect the proteomics market in the long term?

# How is the service market for proteomics moving?

# What are the application areas of the market?

# Which regions are likely to grow at the highest CAGR?

# What are the growth strategies being implemented by major market players?

Factors Influencing Global Growth:-

Growth in this market is driven by an increase in research activity (especially in the areas of personalized medicine and drug discovery). Other market drivers include increasing pharmaceutical and biotechnology R&D expenditure, government funding for proteomics, and technological advancements.

Restraints:

# High Cost of Instruments

Opportunities

# Growing Prominence of Nanoproteomics—The Convergence of Nanotechnology and Proteomics

# Personalized Proteomics for Precision Health

# High Growth Opportunities in Emerging Countries

Challenges:

# Data Management in Proteomics Research

# Low Biomarker Discovery-To-Approval Ratio

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.

Geographical Growth Scenario:

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Leading Market Players:

# Thermo Fisher Scientific, Inc. (US)

# Agilent Technologies, Inc.(US)

# GE Healthcare (US)

# Bio-Rad Laboratories, Inc. (US)

# Danaher Corporation (US)

# Luminex Corporation (US) and many more…

These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, partnerships, agreements, collaborations, joint ventures, and expansions.

Latest Technological Advancements in Sleep Apnea Devices

The study involved four major activities in estimating the current market size for sleep apnea devices. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and sub-segments

Following are the Major Objectives of this Study:

# To define, describe, and measure the global market by type, end user, and region.

# To provide detailed information about major factors influencing market growth (such as drivers, restraints, growth opportunities, and challenges).

# To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the global market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and the Rest of the world (RoW).

# To strategically analyze the market structure and profile key players and their core competencies in the global market.

# To track and analyze competitive developments such as service launches, expansions, acquisitions, partnerships & collaborations; in the market.

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Recent Developments:

# In 2019, ResMed (US) launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the US with a newly designed nasal cradle cushion that sits just under the wearer’s nose.

# In 2016, Koninklijke Philips (Netherlands) launched its Dream Family solution which comprises of a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app.

Key questions addressed by the report:

# Which type segment will dominate the market in the future?

# Emerging countries have immense opportunities for the growth and adoption of sleep apnea devices, therefore will this scenario continue in the next five years?

# Where will all the advancements in technology offered by various companies take the industry in the mid to long term?

# What are the upcoming alternative therapies and devices related to the same in the sleep apnea devices market?

Factors Influencing Global Growth:-

Growth in the sleep apnea devices market can be attributed to factors such the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets.

Restraints:

# High Cost of CPAP Machines

# Complex Referral Pathways and Long Waiting Periods

Opportunities

# Growing Demand for Home Healthcare

# Increasing Focus on Telemedicine and Mhealth (Mobile Health)

Challenges:

# Lack of Patient Compliance

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global sleep apnea devices market is expected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%.

Geographical Growth Scenario:

North America is expected to dominate the sleep apnea devices market during the forecast period

On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period. North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.

Leading Market Players:

# ResMed (US)

# Koninklijke Philips (Netherlands)

# Fisher & Paykel Healthcare (New Zealand)

# SomnoMed (US)

# Oventus Medical (Australia)

# Compumedics (Australia) and many more…

Analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as partnerships & agreements, expansions, service launches, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the sleep apnea devices market.

Clinical Trial Management System - Global Industry Growth Expectations

A clinical trial management system (CTMS) is a software system used to manage clinical trials. It streamlines the clinical trial process and optimizes operational efficiency. This helps reduce the overall cost of conducting clinical trials. CTMS assist companies that conduct clinical trials such as CROs; medical device, pharmaceutical and biotechnology companies to plan, track, and manage clinical trials and their progress.

Following are the Major Objectives of this Study:

# To define, describe, segment, and forecast the global clinical trial management systems market on the basis of components, type, delivery mode, end user, and region.

# To provide detailed information regarding the major factors influencing the overall market growth (drivers, restraints, opportunities, challenges, and trends) across individual geographies

# To analyze micromarkets1 with respect to their individual growth trends, future prospects, and contributions to the overall market

# To analyze growth opportunities in the global clinical trial management system industry for stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to the four key regions—North America (US, Canada), Europe (Germany, UK, France, and RoE), Asia Pacific (China, Japan, India, and RoAPAC), and the Rest of the World (RoW)

# To profile the key players in the global clinical trial management systems market and comprehensively analyze their market shares and core competencies2

# To track and analyze competitive developments such as product launches and product enhancements; agreements, partnerships, and collaborations; mergers and acquisitions; and R&D activities in the CTMS solutions market

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

Target Audience:

# Healthcare IT service providers

# Pharmaceutical/biopharmaceutical companies

# Clinical research organizations

# Research and development (R&D) companies

# Medical device companies

# Business research and consulting service providers

# Academic medical centers/universities/hospitals

Factors Influencing Global Growth:-

Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the overall demand for CTMS across key markets.

Restraints:

# Budget constraints

# Limited awareness among researchers about the advantages of CTMS solutions

Opportunities

# Increased outsourcing of clinical trial processes by industrial researchers to Asian countries/ developing countries CROs

# Increasing use of platform-as-a-service (PaaS) and mobile computing

Challenges:

# Lack of skilled professionals

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global clinical trial management system market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

Geographical Growth Scenario:

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2027). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

Leading Market Players:

# Oracle (US)

# Medidata Solutions (US)

# PAREXEL (US)

# Bioclinica (US)

# Bio-Optronics (US)

# IBM (US) and many more…

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the CTMS market. Among these business strategies, product enhancements, agreements, and partnerships were the most widely adopted growth strategies by the players in the CTMS market.

The New Era of Dental Labs is Here | Get to Know Interesting Facts

Objectives of the Study:

# To define, describe, and forecast the global Dental Lab Market by material, equipment, prosthetic type, and region.

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players.

# To forecast the size of the dental laboratory market, in five main regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa.

# To profile key players in the global dental laboratory market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as research and development activities; joint ventures, alliances, mergers and acquisitions; new product/technology developments; and agreements, partnerships, and other developments of key players in the market.

Target Audience:

# Dental product manufacturers & distributors

# Dental equipment manufacturers & distributors

# Dental laboratories

# Government associations and dental practitioners

# Market research and consulting firms

# Venture capitalists and investors

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223694318

Factors Influencing Global Growth:-

The rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental caries and other periodontal diseases, and the increased outsourcing of certain manufacturing functions to dental laboratories.

Market Restraints:

# High Cost of Dental Equipment and Materials

Market Opportunities:

# Increasing Popularity of CAD/CAM Technology

# Growing Focus of Companies on Emerging Markets

Market Challenges:

# Pricing Pressure Faced By Prominent Market Players

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The dental laboratories market is expected to reach USD 43.08 Billion by 2022 from an estimated USD 32.56 Billion in 2017, at a CAGR of 5.8% during the forecast period.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=223694318

Geographical Growth Scenario:

Europe accounted for the largest share of the dental laboratories devices market in 2016, followed by North America. The rising geriatric population, increasing dental tourism, growth in the number of dental laboratories, growing government expenditure on oral healthcare across Europe, and presence of higher reimbursement rates for dental procedures in Europe as compared to other regions are the key factors driving the growth of the dental laboratories market in Europe.

Leading Market Players:

# DENTSPLY SIRONA Inc. (US)

# Danaher Corporation (US)

# 3M Company (US)

# Ivoclar Vivadent AG (Liechtenstein)

# GC Corporation (Japan)

# Planmeca Oy (Finland) and many more…

Players in the global dental laboratories market, such as DENTSPLY SIRONA Inc. (US), Planmeca Oy (Finland), Ivoclar Vivadent AG (Liechtenstein), VOCO GmbH (Germany), Danaher Corporation (US) are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies. 

Zimmer Biomet Holdings, Inc. (US), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France) are players focusing on organic growth strategies like product launches to enhance their market presence.

... This is Why There is a Constant Need for Advancements in Intraoperative Imaging Systems

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Intraoperative Imaging Market along with the estimates and forecasts of the revenue.

Targeted Audience in This Study:

# Intraoperative imaging equipment manufacturers and suppliers

# Neurosurgical/spinal surgery/orthopedic associations

# Neurosurgical/spinal surgery/orthopedic clinics and hospitals

# Academic institutes and universities

# Medical device manufacturers

# Research and consulting firms

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94836651

Factors Influencing Global Growth:-

The intraoperative imaging market is witnessing significant growth across the globe owing to factors such as the rising geriatric population and subsequent growth in the prevalence of orthopedic, cardiovascular, and neurological conditions. 

In addition, the rising preference for minimally invasive surgeries (MIS) and requirement of superior imaging in orthopedics and neurological procedures are expected to support the growth of this market in the coming years.

Market Restraints:

# High Cost of Intraoperative Imaging Systems

Market Opportunities:

# Emerging Markets

Market Challenges:

# Survival of New Entrants and Small Players

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global Intraoperative Imaging market is projected to reach USD 2.06 Billion by 2021 from USD 1.61 Billion in 2016, at a CAGR of 5.2% during the forecast period of 2016 to 2021.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=94836651

Geographical Growth Scenario:

Currently, North America dominates the intraoperative imaging market, followed by Europe. However, the Asia-Pacific market is expected to witness the highest growth during the forecast period. The high growth in this market can be attributed to infrastructural improvements in healthcare facilities, growth in the geriatric population, increasing prevalence of orthopedic disorders, and growing disposable incomes in this region.

Leading Market Players:

# GE Company (U.S.)

# Siemens AG (Germany)

# Koninklijke Philips N.V. (Netherlands)

# Ziehm Imaging GmbH (Germany)

# Toshiba Corporation (Japan)

# Medtronic (Ireland) and many more…

GE Healthcare, a subsidiary of General Electric Company (U.S.) is the leading player in the intraoperative imaging market. The company’s position is attributed to its strong brand image, robust product portfolio, and wide geographic presence. The company has a strong focus on innovation and quality.

Siemens AG (Germany) has a robust geographic presence in more than 200 countries across the Americas, Asia, Australia, Europe, C.I.S., Africa, and the Middle East. To sustain its position in the intraoperative imaging market, the company focuses on adopting organic growth strategies.

Philips Healthcare, a business segment of Koninklijke Philips NV (Netherlands) held the third position in the intraoperative imaging market. In 1955, a team of engineers from Philips Medical Systems developed the first mobile C-arm. The company has close to six decades of experience in the mobile C-arm segment.

To Get Your Queries Resolved Regarding This Topic – Read the Detailed Article on “Intraoperative Imaging Market - Global Forecast to 2021”, Here..!

Emerging Innovations in Transfection Reagents Techniques - A Boon to the Global Genetics Research Industry

Major Objectives behind this Study:

# To define, describe, segment, and forecast the global Transfection Reagents Market on the basis of product, indication, end user, and region.

# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players.

# To forecast the size of the market, in five main regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

# To profile key players in the global market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global market.

Targeted Audience in This Study:

# Biopharmaceutical companies

# Biotechnology companies

# Transfection equipment, reagent, and kit manufacturing companies

# Suppliers and distributors of transfection reagents

# Research institutes

# Academic centers

# Venture capitalists

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146

Factors Influencing Global Growth:-

Over the years, the transfection reagents and equipment market has witnessed various technological advancements to meet the needs of researchers and biotechnology & pharmaceutical companies. These advancements have led to the development of high throughput large scale transfection instruments and reagents with greater efficiency. Advanced technologies result in efficient quantitative and qualitative transfection in varied types of cells, including the hard-to-transfect cell lines.

Restraints:

# Selective Effectiveness of Transfection Reagents

# Home Brew Reagents Restrict Sale of Commercial Kits

# High Cost of Transfection Reagents

Opportunities:

# Large-Scale Transfections

# High-Growth Opportunities in Asian Market

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global transfection reagent market includes forecast from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=139141146

Geographical Growth Scenario:

North America is expected to account for the largest share of the transfection reagent market, followed by Europe and Asia-Pacific. The largest share can be attributed to the increase in bio-based drug research, increase in demand for protein therapeutics, and increasing investment for development of biologics in the country. The Asia-Pacific transfection reagent market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Leading Market Players:

# Thermo Fisher Scientific Inc. (U.S.)

# Promega Corporation (U.S.)

# Hoffmann-La Roche Ltd. (Switzerland)

# QIAGEN N.V. (Netherlands)

# Polyplus-transfection SA (France)

# Bio-Rad Laboratories (U.S.) and many more…

Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence.

To Get Your Queries Resolved Regarding This Topic – Feel FREE to Connect to Our Research Experts

Respiratory Care Devices Industry is Experiencing Huge Growth Across Geographies

The study involved 4 major activities in estimating the current market size for the Respiratory Care Devices Market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Major Objectives behind this Study:

# To define, describe, segment, and forecast the global respiratory care devices market on the basis of product, indication, end user, and region.

# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players.

# To forecast the size of the market, in five main regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

# To profile key players in the global market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global market.

Find More Details | Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368

Recent Developments:

# In May 2019, Fisher Paykel (New Zealand) launched a nasal cannula - F&P Optiflow 3S, to strengthen its position in the therapeutic respiratory care devices market.

# In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.

# In March 2018, Philips opened its first Sleep and Respiratory Education Center in Singapore.

# In May 2019 Masimo Corporation (US) signed an agreement with Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) to offer Masimo SET Measure-through Motion and Low Perfusion pulse oximetry in its monitoring devices. Mindray devices equipped with SET will now be available in select countries in Europe, the Middle East, Russia, the Commonwealth of Independent States, and the Asia Pacific (excluding China), including Australia and India.

Key Questions Addressed in the Report

# Who are the top 10 players operating in the market?
# What are the drivers, restraints, opportunities, and challenges in the market?
# What are the industry trends as well as the current scenario in the market?
# What are the growth trends in the market at the segmental and overall market levels?
# How is the market performing in different regions across the globe?

Factors Influencing Global Growth:-

The emergence of home healthcare has opened new growth avenues for the respiratory care devices market. Convenience and comfort in a home care environment, coupled with cost advantages, are the major factors driving the growth of the home healthcare market for respiratory care devices.

The major factor driving the growth of the respiratory care devices market is the high prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population, high prevalence of tobacco smoking, urbanization and growing levels of pollution, and changing lifestyles.

However, factors such as the presence of an unfavorable reimbursement scenario and the availability of low-cost products from local manufacturers are expected to restrain the growth of this market during the forecast period.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=368

Opportunities:

# Growing Demand for Home Care Therapeutic Devices
# High Growth in Developing Countries Across APAC and Latin America
# Point-Of-Care Diagnostics - an Upcoming Opportunity

Challenges:
# Low Awareness and Large Underdiagnosed and Undertreated Population
# Harmful Effects of Certain Devices on Neonates

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global respiratory care devices market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1% during the forecast period.

Geographical Growth Scenario:

While the respiratory care devices market in the APAC is relatively smaller than developed markets across North America and Europe, it is expected to grow at the highest rate. This can be attributed to the presence of high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore.

In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and the expansion of private-sector hospitals to rural areas are major factors driving the growth of the respiratory care devices market. Low labor costs and the favorable regulatory environment in the region will also contribute.

Leading Market Players:

# Philips Healthcare (Netherlands)
# ResMed Inc. (US)
# Medtronic plc (Ireland)
# Masimo Corporation (US)
# Fisher & Paykel Healthcare Corporation Limited (New Zealand) and many more…

To Get Your Queries Resolved Regarding This Topic – Feel FREE to Connect to Our Research Experts